Global outreach to improve the provision of cardiopulmonary bypass for patients with congenital heart disease

Matte, Gregory S.

doi:10.1111/aor.13374

Cited by 4 publications

(5 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The aim of this project was ultimately to improve the quality of CPB for the IQIC member sites. The Boston Children’s perfusion team created ten perfusion practice webinars roughly based on the textbook previously published by the project coordinator [ 28 ] .…”

Section: Pediatric Cardiac Surgery In the Brazilian Public Health Car...mentioning

confidence: 99%

A New Dawn for Brazilian Pediatric Cardiac Surgery Is on the Way — Issues Around and Outside the Operating Room

Canêo¹,

Miana²,

Garros³

et al. 2022

Braz J Cardiovasc Surg

View full text Add to dashboard Cite

In some developing countries, congenital heart disease still stands out among the leading causes of death in the first year of life. Therefore, there is a great need to develop programs designed to improve outcomes in the diagnosis and surgical treatment of congenital heart disease in these nations, where children have always been and still are severely underserved. The Brazilian Public Health Care System demands universal access to treatment as a constitutional right. Therefore, an underfunded Pediatric Cardiac Surgery program is unacceptable since it will cost lives and increase the infant mortality rate. Additionally, poor funding decreases providers’ interest, impedes technological advances and multidisciplinary engagement, and reduces access to comprehensive care. Unfortunately, in most developing countries, Pediatric Cardiac Surgery progress is still the result of isolated personal efforts, dedication, and individual resilience. This article aims to present the current state of Brazilian pediatric cardiac surgery and discuss the structural and human limitations in developing a quality care system for children with congenital heart disease. Considering such constraints, quality improvement programs via International collaboration with centers of excellence, based on proper data collection and outcomes analysis, have been introduced in the country. Such initiatives should bring a new dawn to Brazilian Pediatric Cardiac Surgery.

show abstract

Section: Pediatric Cardiac Surgery In the Brazilian Public Health Car...mentioning

confidence: 99%

A New Dawn for Brazilian Pediatric Cardiac Surgery Is on the Way — Issues Around and Outside the Operating Room

Canêo¹,

Miana²,

Garros³

et al. 2022

Braz J Cardiovasc Surg

View full text Add to dashboard Cite

show abstract

“…Perfusion practice during cardiovascular surgery is recognized in the international literature as a critical component to successful patient outcomes. Therefore, as medical societies, we have the responsibility to change our culture, our commercial practices, legislation, regulations and whatever else which involves our specialty which can improve patient outcomes [4,5] . The intent of our proposed standards and guidelines document is to provide a modern framework for the practice of cardiopulmonary bypass in Brazil that can maximize patient safety and outcomes.…”

Section: Why Are Clinical Perfusion Standards So Important?mentioning

confidence: 99%

The Brazilian Society for Cardiovascular Surgery (SBCCV) and Brazilian Society for Extracorporeal Circulation (SBCEC) Standards and Guidelines for Perfusion Practice

Canêo

Matte

Groom³

et al. 2019

Braz J Cardiovasc Surg

View full text Add to dashboard Cite

“…Currently available artificial materials have no growth potential resulting in subsequent relative stenosis, and patients need frequent reoperations throughout their life. 2,3 To date, several TEVG fabrication methods have been developed, including biodegradable conduits, cell sheets, decellularized materials, and 3D bioprinting. [4][5][6][7] These methods have shown promising results in vivo and in vitro, but there remain major limitations, including the lack of clinically applicable cell sources.…”

Section: Introductionmentioning

confidence: 99%

“…Congenital heart diseases are characterized by defects of one or more cardiovascular structures, and patients with congenital heart disease require the implantation of exogenous materials during the neonatal and/or early infant periods. Currently available artificial materials have no growth potential resulting in subsequent relative stenosis, and patients need frequent reoperations throughout their life 2,3 …”

Section: Introductionmentioning

confidence: 99%

Scaffold‐free tissue‐engineered arterial grafts derived from human skeletal myoblasts

et al. 2021

View full text Add to dashboard Cite

Tissue-engineered vascular grafts (TEVGs) are in urgent demand for both adult and pediatric patients. Although several approaches have utilized vascular smooth muscle cells (SMCs) and endothelial cells as cell sources for TEVGs, these cell sources have a limited proliferative capacity that results in an inability to reconstitute neotissues.How to cite this article: Saito J, Yokoyama U, Nakamura T, et al. Scaffold-free tissue-engineered arterial grafts derived from human skeletal myoblasts.

show abstract

Global outreach to improve the provision of cardiopulmonary bypass for patients with congenital heart disease

Cited by 4 publications

References 4 publications

A New Dawn for Brazilian Pediatric Cardiac Surgery Is on the Way — Issues Around and Outside the Operating Room

A New Dawn for Brazilian Pediatric Cardiac Surgery Is on the Way — Issues Around and Outside the Operating Room

The Brazilian Society for Cardiovascular Surgery (SBCCV) and Brazilian Society for Extracorporeal Circulation (SBCEC) Standards and Guidelines for Perfusion Practice

Scaffold‐free tissue‐engineered arterial grafts derived from human skeletal myoblasts

Contact Info

Product

Resources

About